Chorea

• CLINICAL_TRIALS research · 2026-03-18
  Clinical Trial Update: A Retrospective Survey-based Multicenter Study to Delineate the Molecular and Phenotypic Spectrum of Epilepsy-dyskinesia Syndromes

  A multicenter retrospective survey is being conducted to delineate the molecular and phenotypic spectrum of epilepsy-dyskinesia syndromes in…

• CLINICAL_TRIALS trial_result · 2025-11-17
  Clinical Trial Update: Stimulation of the Dentate Nucleus of the Cerebellum for the Treatment of Refractory Spasticity With or Without Dystonia

  A completed clinical trial evaluated stimulation of the dentate nucleus in the cerebellum to treat refractory spasticity with or without dys…

• CLINICAL_TRIALS research · 2025-08-17
  Clinical Trial Update: Registry and Natural History of Epilepsy-Dyskinesia Syndromes

  A Boston Children's Hospital registry study on the registry and natural history of epilepsy-dyskinesia syndromes, currently recruiting.

• CLINICAL_TRIALS trial_result · 2025-03-21
  Clinical Trial Update: Risperidone for the Treatment of Huntington's Disease Involuntary Movements [Phase 2]

  Phase 2 trial evaluating risperidone for involuntary movements in Huntington's disease (chorea) has completed with results posted.

• CLINICAL_TRIALS trial_result · 2017-08-11
  Clinical Trial Update: First Time Use of SD-809 in Huntington Disease [Phase 3]

  Phase 3 trial update on the first use of SD-809 (deutetrabenazine) for Huntington disease–related chorea.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2008-03-04
  Clinical Trial Update: Treatment of Huntington's Chorea With Amantadine [Phase 2]

  Phase 2 clinical trial evaluating amantadine for Huntington's chorea has been completed.